Carmell Corp (CTCX): מחיר למכירות

Carmell Corporation develops bioactive plasma materials to accelerate tissue healing by integrating its regenerative ecosystem into surgical practice. The market capitalization-to-revenue ratio on the GURU.Markets chart visualizes this potential, where 1.60 shapes the current metric. High scientific authority and investor confidence reinforce the professional brand image of CTCX.

The scale of Carmell Corporation (CTCX) operations in the field of regenerative medicine is assessed via the price-to-sales ratio, which compares market capitalization to annual sales volume. This metric determines the cost of each dollar of revenue, allowing investors to evaluate business sustainability considering patent protection and high profitability, which minimizes the risk of overpaying for future growth.